DR LAL PATHLABS
Back to Cashflow Statement
|
DR LAL PATHLABS Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Cash Inflow / Outflow | ₹97 Cr | ₹-114 Cr | ₹134 Cr | ₹48 Cr | ₹67 Cr |
What is the latest Net Cash Inflow / Outflow ratio of DR LAL PATHLABS ?
Year | Net Cash Inflow / Outflow |
---|---|
Mar2024 | ₹97 Cr |
Mar2023 | ₹-114 Cr |
Mar2022 | ₹134 Cr |
Mar2021 | ₹48 Cr |
Mar2020 | ₹67 Cr |
How is Net Cash Inflow / Outflow of DR LAL PATHLABS Trending?
Years | Net Cash Inflow / Outflow | % Change | |
---|---|---|---|
Mar2024 | ₹97 Cr | Positive | |
Mar2023 | ₹-114 Cr | Negative | |
Mar2022 | ₹134 Cr | 181.43 | |
Mar2021 | ₹48 Cr | -29.34 | |
Mar2020 | ₹67 Cr | - |
Compare Net Cash Inflow / Outflow of peers of DR LAL PATHLABS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
DR LAL PATHLABS | ₹25,562.8 Cr | 3.5% | -7.8% | 12.4% | Stock Analytics | |
APOLLO HOSPITALS ENTERPRISE | ₹99,676.6 Cr | 1.1% | 0.7% | 23.1% | Stock Analytics | |
MAX HEALTHCARE INSTITUTE | ₹97,193.8 Cr | -0.6% | 8.3% | 62.9% | Stock Analytics | |
FORTIS HEALTHCARE | ₹51,850.5 Cr | 7.5% | 15.5% | 91.1% | Stock Analytics | |
GLOBAL HEALTH | ₹29,916.2 Cr | 4% | 9.3% | 18.9% | Stock Analytics | |
NARAYANA HRUDAYALAYA | ₹25,991.6 Cr | -0.4% | 0.9% | 2.6% | Stock Analytics |
DR LAL PATHLABS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
DR LAL PATHLABS | 3.5% |
-7.8% |
12.4% |
SENSEX | 1.8% |
-2.5% |
19.9% |
You may also like the below Video Courses